Bio-Techne
TECH
341 hedge funds and large institutions have $5.31B invested in Bio-Techne in 2018 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 105 increasing their positions, 129 reducing their positions, and 31 closing their positions.
39% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 31
3% more funds holding
Funds holding: 332 → 341 (+9)
0.03% more ownership
Funds ownership: 383.63% → 383.66% (+0.03%)
2% less capital invested
Capital invested by funds: $5.43B → $5.31B (-$121M)
19% less repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 129
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
73% less call options, than puts
Call options by funds: $829K | Put options by funds: $3.04M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$79M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$40.9M |
| 3 |
O
OppenheimerFunds
New York
|
+$22.9M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$20.6M |
| 5 |
FAM
Fred Alger Management
New York
|
+$19.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
-$59.3M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$36.3M |
| 3 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$23.1M |
| 4 |
EIP
Epoch Investment Partners
New York
|
-$15.8M |
| 5 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$13.8M |
TECH Hedge Fund Activity: Q2 2018 in Review
341 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2018, worth a combined $5.31B — down 2.2% from $5.43B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new TECH positions and 31 closed out — a net gain of 12 holders — while 105 added to existing stakes and 129 trimmed.
The largest buyer was Champlain Investment Partners, opening a new position worth an estimated $79M. The largest seller was Select Equity Group, cutting an estimated $59.3M.
- 341 institutional investors held Bio-Techne (TECH) as of Q2 2018, up from 332 in Q1 2018.
- Funds reported $5.31B of Bio-Techne stock for Q2 2018, down 2.2% quarter-over-quarter.
- 43 funds opened new Bio-Techne positions in Q2 2018 and 31 closed out, a net change of +12 holders.
- The largest Bio-Techne buyer in Q2 2018 was Champlain Investment Partners, an estimated $79M added.
- The largest Bio-Techne seller in Q2 2018 was Select Equity Group, an estimated $59.3M sold.
Based on aggregated 13F filings for Q2 2018.